Ms Tracey Conroy:

I wish to finish on that matter, from a policy perspective. That is where money follows the patient comes in. That is where the huge opportunity is in terms of diagnosis related group-based, DRG, costing. If one were to do a similar report again, that funding model would be in place and there would be euro signs.